Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity
Descripción del Articulo
Mycobacterium tuberculosis nicotinamidase-pyrazinamidase (PZAse) is a metalloenzyme that catalyzes conversion of nicotinamide-pyrazinamide to nicotinic acid-pyrazinoic acid. This study investigated whether a metallochaperone is required for optimal PZAse activity. M. tuberculosis and Escherichia col...
Autores: | , , , , , , , , , , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2020 |
Institución: | Consejo Nacional de Ciencia Tecnología e Innovación |
Repositorio: | CONCYTEC-Institucional |
Lenguaje: | inglés |
OAI Identifier: | oai:repositorio.concytec.gob.pe:20.500.12390/2651 |
Enlace del recurso: | https://hdl.handle.net/20.500.12390/2651 https://doi.org/10.1128/JB.00331-19 |
Nivel de acceso: | acceso abierto |
Materia: | ZnuA Mechanism of action Mechanism of resistance Metal depletion Metallochaperone Metalloenzyme Mycobacterium tuberculosis Pyrazinamide Pyrazinoic acid PZA resistance Reactivation Resistance Rv2059 http://purl.org/pe-repo/ocde/ford#3.03.08 |
id |
CONC_a4d69e7f68419f25364a5f1d0d098a43 |
---|---|
oai_identifier_str |
oai:repositorio.concytec.gob.pe:20.500.12390/2651 |
network_acronym_str |
CONC |
network_name_str |
CONCYTEC-Institucional |
repository_id_str |
4689 |
dc.title.none.fl_str_mv |
Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity |
title |
Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity |
spellingShingle |
Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity Sheen P. ZnuA Mechanism of action Mechanism of resistance Metal depletion Metallochaperone Metalloenzyme Mycobacterium tuberculosis Pyrazinamide Pyrazinoic acid PZA resistance Reactivation Resistance Rv2059 http://purl.org/pe-repo/ocde/ford#3.03.08 |
title_short |
Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity |
title_full |
Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity |
title_fullStr |
Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity |
title_full_unstemmed |
Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity |
title_sort |
Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity |
author |
Sheen P. |
author_facet |
Sheen P. Monsalve A. Campos J. Huerta R. Antiparra R. Arteaga H. Duran P. Bueno C. Kirwan D.E. Gilman R.H. Zimic M. |
author_role |
author |
author2 |
Monsalve A. Campos J. Huerta R. Antiparra R. Arteaga H. Duran P. Bueno C. Kirwan D.E. Gilman R.H. Zimic M. |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Sheen P. Monsalve A. Campos J. Huerta R. Antiparra R. Arteaga H. Duran P. Bueno C. Kirwan D.E. Gilman R.H. Zimic M. |
dc.subject.none.fl_str_mv |
ZnuA |
topic |
ZnuA Mechanism of action Mechanism of resistance Metal depletion Metallochaperone Metalloenzyme Mycobacterium tuberculosis Pyrazinamide Pyrazinoic acid PZA resistance Reactivation Resistance Rv2059 http://purl.org/pe-repo/ocde/ford#3.03.08 |
dc.subject.es_PE.fl_str_mv |
Mechanism of action Mechanism of resistance Metal depletion Metallochaperone Metalloenzyme Mycobacterium tuberculosis Pyrazinamide Pyrazinoic acid PZA resistance Reactivation Resistance Rv2059 |
dc.subject.ocde.none.fl_str_mv |
http://purl.org/pe-repo/ocde/ford#3.03.08 |
description |
Mycobacterium tuberculosis nicotinamidase-pyrazinamidase (PZAse) is a metalloenzyme that catalyzes conversion of nicotinamide-pyrazinamide to nicotinic acid-pyrazinoic acid. This study investigated whether a metallochaperone is required for optimal PZAse activity. M. tuberculosis and Escherichia coli PZAses (PZAse-MT and PZAse-EC, respectively) were inactivated by metal depletion (giving PZAse-MT–Apo and PZAse-EC–Apo). Reactivation with the E. coli metallochaperone ZnuA or Rv2059 (the M. tuberculosis analog) was measured. This was repeated following proteolytic and thermal treatment of ZnuA and Rv2059. The CDC1551 M. tuberculosis reference strain had the Rv2059 coding gene knocked out, and PZA susceptibility and the pyrazinoic acid (POA) efflux rate were measured. ZnuA (200 M) achieved 65% PZAse-EC–Apo reactivation. Rv2059 (1 M) and ZnuA (1 M) achieved 69% and 34.3% PZAse-MT–Apo reactivation, respectively. Proteolytic treatment of ZnuA and Rv2059 and application of three (but not one) thermal shocks to ZnuA significantly reduced the capacity to reactivate PZAse-MT–Apo. An M. tuberculosis Rv2059 knockout strain was Wayne positive and susceptible to PZA and did not have a significantly different POA efflux rate than the reference strain, although a trend toward a lower efflux rate was observed after knockout. The metallochaperone Rv2059 restored the activity of metal-depleted PZAse in vitro. Although Rv2059 is important in vitro, it seems to have a smaller effect on PZA susceptibility in vivo. It may be important to mechanisms of action and resistance to pyrazinamide in M. tuberculosis. Further studies are needed for confirmation. IMPORTANCE Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis and remains one of the major causes of disease and death worldwide. Pyrazinamide is a key drug used in the treatment of tuberculosis, yet its mechanism of action is not fully understood, and testing strains of M. tuberculosis for pyrazinamide resistance is not easy with the tools that are presently available. The significance of the present research is that a metallochaperone-like protein may be crucial to pyrazinamide’s mechanisms of action and of resistance. This may support the development of improved tools to detect pyrazinamide resistance, which would have significant implications for the clinical management of patients with tuberculosis: drug regimens that are appropriately tailored to the resistance profile of a patient’s individual strain lead to better clinical outcomes, reduced onward transmission of infection, and reduction of the development of resistant strains that are more challenging and expensive to treat. Copyright © 2020 Sheen et al. |
publishDate |
2020 |
dc.date.accessioned.none.fl_str_mv |
2024-05-30T23:13:38Z |
dc.date.available.none.fl_str_mv |
2024-05-30T23:13:38Z |
dc.date.issued.fl_str_mv |
2020 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.12390/2651 |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1128/JB.00331-19 |
dc.identifier.scopus.none.fl_str_mv |
2-s2.0-85077475190 |
url |
https://hdl.handle.net/20.500.12390/2651 https://doi.org/10.1128/JB.00331-19 |
identifier_str_mv |
2-s2.0-85077475190 |
dc.language.iso.none.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.none.fl_str_mv |
Journal of Bacteriology |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.uri.none.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
dc.publisher.none.fl_str_mv |
American Society for Microbiology |
publisher.none.fl_str_mv |
American Society for Microbiology |
dc.source.none.fl_str_mv |
reponame:CONCYTEC-Institucional instname:Consejo Nacional de Ciencia Tecnología e Innovación instacron:CONCYTEC |
instname_str |
Consejo Nacional de Ciencia Tecnología e Innovación |
instacron_str |
CONCYTEC |
institution |
CONCYTEC |
reponame_str |
CONCYTEC-Institucional |
collection |
CONCYTEC-Institucional |
bitstream.url.fl_str_mv |
https://repositorio.concytec.gob.pe/bitstreams/3df4eede-8f12-4463-b559-722063cade67/download https://repositorio.concytec.gob.pe/bitstreams/ef55fc7c-9f5f-40d1-ad80-a5f50d3932f2/download https://repositorio.concytec.gob.pe/bitstreams/f7cbb341-76ed-4a44-84ca-040bb176affd/download |
bitstream.checksum.fl_str_mv |
54bdfad67e52703f12134d616c848ac3 7bb1c8ce008c25db5edfacc65a760fe4 f08fe950e375a3b4224a1f81d1b022f4 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional CONCYTEC |
repository.mail.fl_str_mv |
repositorio@concytec.gob.pe |
_version_ |
1839175760833675264 |
spelling |
Publicationrp00526600rp06845600rp06843600rp06846600rp00913600rp02304600rp06842600rp06844600rp06568600rp00604600rp00606600Sheen P.Monsalve A.Campos J.Huerta R.Antiparra R.Arteaga H.Duran P.Bueno C.Kirwan D.E.Gilman R.H.Zimic M.2024-05-30T23:13:38Z2024-05-30T23:13:38Z2020https://hdl.handle.net/20.500.12390/2651https://doi.org/10.1128/JB.00331-192-s2.0-85077475190Mycobacterium tuberculosis nicotinamidase-pyrazinamidase (PZAse) is a metalloenzyme that catalyzes conversion of nicotinamide-pyrazinamide to nicotinic acid-pyrazinoic acid. This study investigated whether a metallochaperone is required for optimal PZAse activity. M. tuberculosis and Escherichia coli PZAses (PZAse-MT and PZAse-EC, respectively) were inactivated by metal depletion (giving PZAse-MT–Apo and PZAse-EC–Apo). Reactivation with the E. coli metallochaperone ZnuA or Rv2059 (the M. tuberculosis analog) was measured. This was repeated following proteolytic and thermal treatment of ZnuA and Rv2059. The CDC1551 M. tuberculosis reference strain had the Rv2059 coding gene knocked out, and PZA susceptibility and the pyrazinoic acid (POA) efflux rate were measured. ZnuA (200 M) achieved 65% PZAse-EC–Apo reactivation. Rv2059 (1 M) and ZnuA (1 M) achieved 69% and 34.3% PZAse-MT–Apo reactivation, respectively. Proteolytic treatment of ZnuA and Rv2059 and application of three (but not one) thermal shocks to ZnuA significantly reduced the capacity to reactivate PZAse-MT–Apo. An M. tuberculosis Rv2059 knockout strain was Wayne positive and susceptible to PZA and did not have a significantly different POA efflux rate than the reference strain, although a trend toward a lower efflux rate was observed after knockout. The metallochaperone Rv2059 restored the activity of metal-depleted PZAse in vitro. Although Rv2059 is important in vitro, it seems to have a smaller effect on PZA susceptibility in vivo. It may be important to mechanisms of action and resistance to pyrazinamide in M. tuberculosis. Further studies are needed for confirmation. IMPORTANCE Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis and remains one of the major causes of disease and death worldwide. Pyrazinamide is a key drug used in the treatment of tuberculosis, yet its mechanism of action is not fully understood, and testing strains of M. tuberculosis for pyrazinamide resistance is not easy with the tools that are presently available. The significance of the present research is that a metallochaperone-like protein may be crucial to pyrazinamide’s mechanisms of action and of resistance. This may support the development of improved tools to detect pyrazinamide resistance, which would have significant implications for the clinical management of patients with tuberculosis: drug regimens that are appropriately tailored to the resistance profile of a patient’s individual strain lead to better clinical outcomes, reduced onward transmission of infection, and reduction of the development of resistant strains that are more challenging and expensive to treat. Copyright © 2020 Sheen et al.Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - ConcytecengAmerican Society for MicrobiologyJournal of Bacteriologyinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/ZnuAMechanism of action-1Mechanism of resistance-1Metal depletion-1Metallochaperone-1Metalloenzyme-1Mycobacterium tuberculosis-1Pyrazinamide-1Pyrazinoic acid-1PZA resistance-1Reactivation-1Resistance-1Rv2059-1http://purl.org/pe-repo/ocde/ford#3.03.08-1Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activityinfo:eu-repo/semantics/articlereponame:CONCYTEC-Institucionalinstname:Consejo Nacional de Ciencia Tecnología e Innovacióninstacron:CONCYTEC#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#ORIGINALMetallochaperones Are Needed for Mycobacterium tuberculosis.pdfMetallochaperones Are Needed for Mycobacterium tuberculosis.pdfapplication/pdf2119044https://repositorio.concytec.gob.pe/bitstreams/3df4eede-8f12-4463-b559-722063cade67/download54bdfad67e52703f12134d616c848ac3MD51TEXTMetallochaperones Are Needed for Mycobacterium tuberculosis.pdf.txtMetallochaperones Are Needed for Mycobacterium tuberculosis.pdf.txtExtracted texttext/plain66472https://repositorio.concytec.gob.pe/bitstreams/ef55fc7c-9f5f-40d1-ad80-a5f50d3932f2/download7bb1c8ce008c25db5edfacc65a760fe4MD52THUMBNAILMetallochaperones Are Needed for Mycobacterium tuberculosis.pdf.jpgMetallochaperones Are Needed for Mycobacterium tuberculosis.pdf.jpgGenerated Thumbnailimage/jpeg5647https://repositorio.concytec.gob.pe/bitstreams/f7cbb341-76ed-4a44-84ca-040bb176affd/downloadf08fe950e375a3b4224a1f81d1b022f4MD5320.500.12390/2651oai:repositorio.concytec.gob.pe:20.500.12390/26512025-01-18 22:00:33.614https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessopen accesshttps://repositorio.concytec.gob.peRepositorio Institucional CONCYTECrepositorio@concytec.gob.pe#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="d137f387-1373-4d4d-9ae9-d57f73d88610"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>eng</Language> <Title>Metallochaperones are needed for mycobacterium tuberculosis and Escherichia coli nicotinamidase-pyrazinamidase activity</Title> <PublishedIn> <Publication> <Title>Journal of Bacteriology</Title> </Publication> </PublishedIn> <PublicationDate>2020</PublicationDate> <DOI>https://doi.org/10.1128/JB.00331-19</DOI> <SCP-Number>2-s2.0-85077475190</SCP-Number> <Authors> <Author> <DisplayName>Sheen P.</DisplayName> <Person id="rp00526" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Monsalve A.</DisplayName> <Person id="rp06845" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Campos J.</DisplayName> <Person id="rp06843" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Huerta R.</DisplayName> <Person id="rp06846" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Antiparra R.</DisplayName> <Person id="rp00913" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Arteaga H.</DisplayName> <Person id="rp02304" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Duran P.</DisplayName> <Person id="rp06842" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Bueno C.</DisplayName> <Person id="rp06844" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Kirwan D.E.</DisplayName> <Person id="rp06568" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Gilman R.H.</DisplayName> <Person id="rp00604" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Zimic M.</DisplayName> <Person id="rp00606" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>American Society for Microbiology</DisplayName> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by/4.0/</License> <Keyword>ZnuA</Keyword> <Keyword>Mechanism of action</Keyword> <Keyword>Mechanism of resistance</Keyword> <Keyword>Metal depletion</Keyword> <Keyword>Metallochaperone</Keyword> <Keyword>Metalloenzyme</Keyword> <Keyword>Mycobacterium tuberculosis</Keyword> <Keyword>Pyrazinamide</Keyword> <Keyword>Pyrazinoic acid</Keyword> <Keyword>PZA resistance</Keyword> <Keyword>Reactivation</Keyword> <Keyword>Resistance</Keyword> <Keyword>Rv2059</Keyword> <Abstract>Mycobacterium tuberculosis nicotinamidase-pyrazinamidase (PZAse) is a metalloenzyme that catalyzes conversion of nicotinamide-pyrazinamide to nicotinic acid-pyrazinoic acid. This study investigated whether a metallochaperone is required for optimal PZAse activity. M. tuberculosis and Escherichia coli PZAses (PZAse-MT and PZAse-EC, respectively) were inactivated by metal depletion (giving PZAse-MT–Apo and PZAse-EC–Apo). Reactivation with the E. coli metallochaperone ZnuA or Rv2059 (the M. tuberculosis analog) was measured. This was repeated following proteolytic and thermal treatment of ZnuA and Rv2059. The CDC1551 M. tuberculosis reference strain had the Rv2059 coding gene knocked out, and PZA susceptibility and the pyrazinoic acid (POA) efflux rate were measured. ZnuA (200 M) achieved 65% PZAse-EC–Apo reactivation. Rv2059 (1 M) and ZnuA (1 M) achieved 69% and 34.3% PZAse-MT–Apo reactivation, respectively. Proteolytic treatment of ZnuA and Rv2059 and application of three (but not one) thermal shocks to ZnuA significantly reduced the capacity to reactivate PZAse-MT–Apo. An M. tuberculosis Rv2059 knockout strain was Wayne positive and susceptible to PZA and did not have a significantly different POA efflux rate than the reference strain, although a trend toward a lower efflux rate was observed after knockout. The metallochaperone Rv2059 restored the activity of metal-depleted PZAse in vitro. Although Rv2059 is important in vitro, it seems to have a smaller effect on PZA susceptibility in vivo. It may be important to mechanisms of action and resistance to pyrazinamide in M. tuberculosis. Further studies are needed for confirmation. IMPORTANCE Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis and remains one of the major causes of disease and death worldwide. Pyrazinamide is a key drug used in the treatment of tuberculosis, yet its mechanism of action is not fully understood, and testing strains of M. tuberculosis for pyrazinamide resistance is not easy with the tools that are presently available. The significance of the present research is that a metallochaperone-like protein may be crucial to pyrazinamide’s mechanisms of action and of resistance. This may support the development of improved tools to detect pyrazinamide resistance, which would have significant implications for the clinical management of patients with tuberculosis: drug regimens that are appropriately tailored to the resistance profile of a patient’s individual strain lead to better clinical outcomes, reduced onward transmission of infection, and reduction of the development of resistant strains that are more challenging and expensive to treat. Copyright © 2020 Sheen et al.</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication> -1 |
score |
13.210282 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).